Eurazeo Financials

RF Stock  EUR 69.90  0.30  0.43%   
Financial data analysis helps to check if markets are presently mispricing Eurazeo. We were able to interpolate data for thirty-eight available fundamental indicators for Eurazeo, which can be compared to its peers. The stock experiences a normal upward fluctuation. Check odds of Eurazeo to be traded at €73.4 in 90 days.
  
Understanding current and past Eurazeo Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Eurazeo's financial statements are interrelated, with each one affecting the others. For example, an increase in Eurazeo's assets may result in an increase in income on the income statement.
Please note, the presentation of Eurazeo's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eurazeo's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Eurazeo's management manipulating its earnings.

Eurazeo Stock Summary

Eurazeo competes with Amundi SA, Tikehau Capital, Antin IP, Altamir SCA, and ABC Arbitrage. Eurazeo SE is a private equity and venture capital firm specializing in growth capital, leveraged buyouts, and buyins of a private company, and investments in mid-market and listed public companies. Eurazeo SE was founded in 1969 and is based in Paris, France with additional offices in North America, Asia, Europe and South America. EURAZEO operates under Financial Services classification in France and is traded on Paris Stock Exchange. It employs 20294 people.
Foreign Associate
  USA
InstrumentFrance Stock View All
ExchangeEuronext Paris
ISINFR0000121121
Business Address1 rue Georges
SectorFinancial Services
IndustryAsset Management
BenchmarkDow Jones Industrial
Websitewww.eurazeo.com/en/
Phone33 1 44 15 01 11
CurrencyEUR - Euro
You should never invest in Eurazeo without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Eurazeo Stock, because this is throwing your money away. Analyzing the key information contained in Eurazeo's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Eurazeo Key Financial Ratios

Eurazeo's financial ratios allow both analysts and investors to convert raw data from Eurazeo's financial statements into concise, actionable information that can be used to evaluate the performance of Eurazeo over time and compare it to other companies across industries.

Eurazeo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eurazeo's current stock value. Our valuation model uses many indicators to compare Eurazeo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurazeo competition to find correlations between indicators driving Eurazeo's intrinsic value. More Info.
Eurazeo is rated second in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about  0.38  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurazeo is roughly  2.64 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Eurazeo by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eurazeo's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Eurazeo Systematic Risk

Eurazeo's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eurazeo volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Eurazeo correlated with the market. If Beta is less than 0 Eurazeo generally moves in the opposite direction as compared to the market. If Eurazeo Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eurazeo is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eurazeo is generally in the same direction as the market. If Beta > 1 Eurazeo moves generally in the same direction as, but more than the movement of the benchmark.

Eurazeo November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Eurazeo help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eurazeo. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eurazeo based on widely used predictive technical indicators. In general, we focus on analyzing Eurazeo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eurazeo's daily price indicators and compare them against related drivers.

Complementary Tools for Eurazeo Stock analysis

When running Eurazeo's price analysis, check to measure Eurazeo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurazeo is operating at the current time. Most of Eurazeo's value examination focuses on studying past and present price action to predict the probability of Eurazeo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurazeo's price. Additionally, you may evaluate how the addition of Eurazeo to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets